Loading stock data…
$3.40-0.58 (-14.49%)
Impact BioMedical Inc.
Impact BioMedical Inc. in the Healthcare sector is trading at $3.40 with a market capitalization of $50M. The stock is currently near its 52-week low of $3.25, remaining 47.2% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 7 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3,000↓ | $7,000 | $7,000↓ | $18,000↑ | $7,000 |
| Gross Profit | $2,000 | — | -$415,000↓ | $17,000↑ | $6,000 |
| Operating Income | -$702,000↑ | -$2.29M↓ | -$1.16M↓ | -$948,000↑ | -$1.15M |
| Net Income | -$699,000↑ | -$2.29M↓ | $5.25M↑ | -$1.47M↑ | -$14.35M |
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products ...